Monophosphoryl lipid a attenuates myocardial stunning in dogs: Role of ATP-sensitive potassium channels

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 1, 1998, Pages 49-56

  Elliott, Gary T ^a   Mei, David A ^b   Gross, Garrett J ^b  

^a GLAXOSMITHKLINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cardioprotection; Glibenclamide; K(ATP) channels; MLA; Monophosphoryl lipid A; Myocardium; Stunning

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; PHOSPHORYL LIPID A; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG ANTAGONISM; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; STUNNED HEART MUSCLE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CORONARY CIRCULATION; DECANOIC ACIDS; DOGS; FEMALE; GLYBURIDE; HEART RATE; HYDROGEN-ION CONCENTRATION; HYDROXY ACIDS; HYPOGLYCEMIC AGENTS; LIPID A; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL STUNNING; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; VENTRICULAR FUNCTION, LEFT;

EID: 0031778571     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199807000-00008     Document Type: Article

References (41)

1. Kukreja RC, Janin Y. Reperfusion injury: basic concepts and protection strategies. J Thromb Thrombol 1997;4:7-24.
2. Weber PA, Elliott GT. Reperfusion stimulated inflammatory response: role in lethal reperfusion injury. J Thromb Thrombol 1997;4:95-7.
3. Murray CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
4. Van Winkle DM, Thornton JD, Downey DM, Downey JM. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coron Artery Dis 1991;2:613-9.
5. Banerjee A, Locke-Winter C, Rogers KB, et al. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism. Circ Res 1993;73(4):656-70.
6. Schulz R, Post H, Sakka S, Wallbridge DR, Heusch G. Intraischemic preconditioning. Circ Res 1995;76:942-50.
7. Murray CE, Richard VJ, Jennings RB, Reimer KA. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 1991;260:H796-804.
8. Bolli R. The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview. Basic Res Cardiol 1996;91(1):57-63.
9. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993;88:1264-72.
10. Sun JZ, Tang XL, Park SW, Qiu YM, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest 1996;97(2):562-76.
11. Yao Z, Auchampach JA, Pieper GM, Gross GJ. Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog. Cardiovasc Res 1993;27:832-8.
12. Yao Z, Rasmussen JL, Hirt JL, Mei DA, Pieper GM, Gross GJ. Effects of monophosphoryl lipid A on myocardial ischemia/reperfusion injury in dogs. J Cardiovasc Pharmacol 1993;22:653-63.
13. Przyklenk K, Zhao L, Kloner RA, Elliott GT. Cardioprotection with ischemic preconditioning and monophosphoryl lipid A: role of adenosine regulating enzymes? Am J Physiol 1996:271(Heart Circ Physiol 40):H1004-14.
14. Elliott GT, Comerford ML, Smith JR, Zhao L. Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide. Cardiovasc Res 1996;32:1071-80.
15. Yoshida K, Maaieh MM, Shipley JB, et al. Monophosphoryl lipid A induces pharmacologic "preconditioning" in rabbit hearts without concomitant expression of 70-kDa heat shock protein. Mol Cell Biochem 1996;156:1-8.
16. Baxter GF, Goodwin RW, Wright MJ, Kerac M, Heads RJ, Yellon DM. Myocardial protection after monophosphoryl lipid A: studies of delayed anti-ischaemic properties in rabbit heart. Br J Pharmacol 1996;117:1685-92.
17. Nelson DW, Brown JM, Banerjee A, et al. Pretreatment with a nontoxic derivative of endotoxin induces functional protection against cardiac ischemia/reperfusion injury. Surgery 1991;110:365-9.
18. Abd-Elfattah AS, Guo J, El-Sigaby NR, Elliott GT, Shebab MI. Intravenous administration of monophosphoryl lipid A (MLA) 24 hours before aortic cross-clamping attenuates myocardial stunning in dogs. J Mol Cell Cardiol 1995;27:A49.
19. ATP channels mediate the infarct reducing effect of late preconditioning produced by monophosphoryl lipid A. Am J Physiol 1996;271(Heart Circ Physiol 40): H2723-9.
20. ATP channel. J Cardiovasc Pharmacol (in press).
21. Yao Z, Elliott GT, Gross GJ. Monophosphoryl lipid A preserves myocardial contractile function following multiple, brief periods of coronary occlusion in dogs. Pharmacology 1995;51:152-9.
22. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-30.
23. ATP) channels. Anesthesiology 1996;85:794-807.
24. Weber PA, Smart M, Comerford M, Smith J, Zhao L, Elliott GT. Monophosphoryl lipid A mimics both the first and second window of ischemic preconditioning and preserves myocardial sarcoplasmic reticular calcium pump. J Mol Cell Cardiol (in press).
25. Vegh A, Papp JG, Parratt JR. Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol 1994;113:1081-2.
26. Warltier DC, Auchampach JA, Gross GJ. Relationship of severity of myocardial stunning to ATP dependent potassium channel modulation. J Card Surg 1993;8(2):279-83.
27. ATP channel in insulin-secreting cells. J Gen Physiol 1996;107:231-41.
28. - conductance. Circ Res 1995;77:417-23.
29. Wu CC, Thiermermann C, Vane JR. Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat. Br J Pharmacol 1995;114:1273-81.
30. Zhao L, Weber PA, Smith JR, Comerford ML, Elliott GT. Role of inducible nitric oxide synthase (iNOS) in pharmacological "preconditioning" with monophosphoryl lipid A. J Mol Cell Cardiol 1997;29: 1567-76
31. Parratt J. Possibilities for the pharmacological exploitation of ischaemic preconditioning. J Mol Cell Cardiol 1996;27:991-1000.
32. Maulik N, Engelman DT, Watanabe M, et al. Nitric oxide signaling in ischemic heart. Cardiovasc Res 1995;30:593-601.
33. Maulik N, Engelman DT, Watanabe M, et al. Nitric oxide carbon monoxide: a molecular switch for myocardial preservation during ischemia. Circulation 1996;94:11398-406.
34. Cameron JS, Kibler KKA, Berry H, Barron DN, Sodder VH. Nitric oxide activates ATP-sensitive potassium channels in hypertrophied ventricular myocytes. FASEB J 1996;10:A65.
35. Shindo T, Ikeda U, Ohkawa F, Kawahara Y, Yokoyama M, Shimada K. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res 1995;29:813-9.
36. McKenna TM, Li S, Tao S. PKC mediates LPS and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility. Am J Physiol 1995;269(Heart Circ Physiol 38):H1891-8.
37. Kong L-Y, McMillian MK, Maronpot R, Hong J-S. Protein tyrosine kinase inhibitors suppress the production of nitric oxide in mixed glia, microglia-enriched or astrocyte-enriched cultures. Brain Res 1996;729:102-9.
38. Maulik N, Elliott G, Engelman RM, Maulik G, Das DK. Induction of iNOS expression by monophosphoryl lipid A: a pharmacological approach for myocardial adaptation to ischemia. Int J Tissue React 1997;19(1/2):35.
39. Pan J, Burgher KL, Szczepanik AM, Ringheim GE. Tyrosme phosphorylation of inducible nitric oxide synthase: implications for potential post-translational regulation. Biochem J 1996;314:889-94.
40. Nayeen MA, Elliott GT, Hastillo-Hess SL, Kukreja RC. Monophosphoryl lipid A protects adult rat cardiomyocytes with induction of the 72-kD heat shock protein. J Mol Cell Cardiol (in press).
41. Liu SF, Barnes PJ, Evans TW. Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo. Crit Care Med 1997;25(3):512-8.